Selegiline use to prevent progression of Parkinson's disease. Experience in 22 de novo patients.
about
Idiopathic Parkinson's disease: epidemiology, diagnosis and management.Antioxidative therapeutic strategies for Parkinson's disease.Drug treatment of Parkinson's disease: is "polypharmacy" best?A rationale for monoamine oxidase inhibition as neuroprotective therapy for Parkinson's disease.Nigral degeneration in Parkinson's disease.
P2860
Selegiline use to prevent progression of Parkinson's disease. Experience in 22 de novo patients.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
1989年论文
@zh
1989年论文
@zh-cn
name
Selegiline use to prevent prog ...... rience in 22 de novo patients.
@en
type
label
Selegiline use to prevent prog ...... rience in 22 de novo patients.
@en
prefLabel
Selegiline use to prevent prog ...... rience in 22 de novo patients.
@en
P2093
P1433
P1476
Selegiline use to prevent prog ...... rience in 22 de novo patients.
@en
P2093
P304
P356
10.1001/ARCHNEUR.1989.00520480017012
P577
1989-12-01T00:00:00Z